JonathanAlfredFletcherMD

Medical Genetics • Boston, MA

Clinical Cytogenetics

Associate Professor of Pathology, Brigham and Women's Hospital

Join to view full profile

Dr. Fletcher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fletcher's full profile

Already have an account?

Office
75 Francis St
# Brigham
Boston, MA 02115
Phone+1 617-732-7883

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1988
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
Boston University Medical CenterResidency, Internal Medicine, 1981 - 1985
Boston University School of MedicineClass of 1981

Certifications & Licensure

MA State Medical License 1985 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Medical Genetics and Genomics Clinical Cytogenetics

Publications & Presentations

PubMed

193 citations
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
Jeffrey S. Ross, Jonathan A. Fletcher
American Journal of Clinical Pathology. 1999-07-01
506 citations
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
Brandon D. Lawrence, Antonio R. Perez-Atayde, Michele K. Hibbard, Brian P. Rubin, Paola Dal Cin
The American Journal of Pathology. 2000-08-01
172 citations
Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish.
Chuan Yan, Dalton C. Brunson, Qin Tang, Daniel Do, Nicolae A. Iftimia
Cell. 2019-06-13

Journal Articles

LMTK3 Is Essential for Oncogenic KIT Expression in KIT-Mutant GIST and Melanoma
Jonathan A Fletcher, William H Fleming, Nature

Press Mentions

Demetri’s Team Approach Translates into Success in Sarcoma ResearchFebruary 10th, 2016

Grant Support

Core--Molecular CytogeneticsNational Cancer Institute2000–2002
Translocation Of 8-13 In Stem-Cell Leukemia/LymphomaNational Cancer Institute1997–1999
Tumor Suppressor Loci In MesotheliomaNational Cancer Institute1996–1998
Molecular Cytogenetics Of Solid TumorsNational Cancer Institute1990–1994